These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

733 related items for PubMed ID: 16528474

  • 1. JNK and AP-1 mediate apoptosis induced by bortezomib in HepG2 cells via FasL/caspase-8 and mitochondria-dependent pathways.
    Lauricella M, Emanuele S, D'Anneo A, Calvaruso G, Vassallo B, Carlisi D, Portanova P, Vento R, Tesoriere G.
    Apoptosis; 2006 Apr; 11(4):607-25. PubMed ID: 16528474
    [Abstract] [Full Text] [Related]

  • 2. SAHA induces apoptosis in hepatoma cells and synergistically interacts with the proteasome inhibitor Bortezomib.
    Emanuele S, Lauricella M, Carlisi D, Vassallo B, D'Anneo A, Di Fazio P, Vento R, Tesoriere G.
    Apoptosis; 2007 Jul; 12(7):1327-38. PubMed ID: 17351739
    [Abstract] [Full Text] [Related]

  • 3. Synergistic induction of oxidative injury and apoptosis in human multiple myeloma cells by the proteasome inhibitor bortezomib and histone deacetylase inhibitors.
    Pei XY, Dai Y, Grant S.
    Clin Cancer Res; 2004 Jun 01; 10(11):3839-52. PubMed ID: 15173093
    [Abstract] [Full Text] [Related]

  • 4. Hsp72 controls bortezomib-induced HepG2 cell death via interaction with pro-apoptotic factors.
    Calvaruso G, Giuliano M, Portanova P, Pellerito O, Vento R, Tesoriere G.
    Oncol Rep; 2007 Aug 01; 18(2):447-50. PubMed ID: 17611669
    [Abstract] [Full Text] [Related]

  • 5. Mitomycin-C induces the apoptosis of human Tenon's capsule fibroblast by activation of c-Jun N-terminal kinase 1 and caspase-3 protease.
    Seong GJ, Park C, Kim CY, Hong YJ, So HS, Kim SD, Park R.
    Invest Ophthalmol Vis Sci; 2005 Oct 01; 46(10):3545-52. PubMed ID: 16186332
    [Abstract] [Full Text] [Related]

  • 6. Combined proteasome and Bcl-2 inhibition stimulates apoptosis and inhibits growth in EBV-transformed lymphocytes: a potential therapeutic approach to EBV-associated lymphoproliferative diseases.
    Srimatkandada P, Loomis R, Carbone R, Srimatkandada S, Lacy J.
    Eur J Haematol; 2008 May 01; 80(5):407-18. PubMed ID: 18221384
    [Abstract] [Full Text] [Related]

  • 7. Berberine induces apoptosis in SW620 human colonic carcinoma cells through generation of reactive oxygen species and activation of JNK/p38 MAPK and FasL.
    Hsu WH, Hsieh YS, Kuo HC, Teng CY, Huang HI, Wang CJ, Yang SF, Liou YS, Kuo WH.
    Arch Toxicol; 2007 Oct 01; 81(10):719-28. PubMed ID: 17673978
    [Abstract] [Full Text] [Related]

  • 8. Effects of antioxidants and caspase-3 inhibitor on the phenylethyl isothiocyanate-induced apoptotic signaling pathways in human PLC/PRF/5 cells.
    Wu SJ, Ng LT, Lin CC.
    Eur J Pharmacol; 2005 Aug 22; 518(2-3):96-106. PubMed ID: 16054126
    [Abstract] [Full Text] [Related]

  • 9. Effects of the proteasome inhibitor, bortezomib, on apoptosis in isolated lymphocytes obtained from patients with chronic lymphocytic leukemia.
    Pahler JC, Ruiz S, Niemer I, Calvert LR, Andreeff M, Keating M, Faderl S, McConkey DJ.
    Clin Cancer Res; 2003 Oct 01; 9(12):4570-7. PubMed ID: 14555532
    [Abstract] [Full Text] [Related]

  • 10. Bortezomib abolishes tumor necrosis factor-related apoptosis-inducing ligand resistance via a p21-dependent mechanism in human bladder and prostate cancer cells.
    Lashinger LM, Zhu K, Williams SA, Shrader M, Dinney CP, McConkey DJ.
    Cancer Res; 2005 Jun 01; 65(11):4902-8. PubMed ID: 15930312
    [Abstract] [Full Text] [Related]

  • 11. The proteasome inhibitor bortezomib acts independently of p53 and induces cell death via apoptosis and mitotic catastrophe in B-cell lymphoma cell lines.
    Strauss SJ, Higginbottom K, Jüliger S, Maharaj L, Allen P, Schenkein D, Lister TA, Joel SP.
    Cancer Res; 2007 Mar 15; 67(6):2783-90. PubMed ID: 17363600
    [Abstract] [Full Text] [Related]

  • 12. Critical roles for JNK, c-Jun, and Fas/FasL-Signaling in vitamin E analog-induced apoptosis in human prostate cancer cells.
    Jia L, Yu W, Wang P, Li J, Sanders BG, Kline K.
    Prostate; 2008 Mar 01; 68(4):427-41. PubMed ID: 18196534
    [Abstract] [Full Text] [Related]

  • 13. Molecular mechanisms of echinocystic acid-induced apoptosis in HepG2 cells.
    Tong X, Lin S, Fujii M, Hou DX.
    Biochem Biophys Res Commun; 2004 Aug 27; 321(3):539-46. PubMed ID: 15358141
    [Abstract] [Full Text] [Related]

  • 14. Anandamide-induced apoptosis in Chang liver cells involves ceramide and JNK/AP-1 pathway.
    Giuliano M, Calvaruso G, Pellerito O, Portanova P, Carlisi D, Vento R, Tesoriere G.
    Int J Mol Med; 2006 May 27; 17(5):811-9. PubMed ID: 16596265
    [Abstract] [Full Text] [Related]

  • 15. Curcumin downregulates cell survival mechanisms in human prostate cancer cell lines.
    Mukhopadhyay A, Bueso-Ramos C, Chatterjee D, Pantazis P, Aggarwal BB.
    Oncogene; 2001 Nov 15; 20(52):7597-609. PubMed ID: 11753638
    [Abstract] [Full Text] [Related]

  • 16. Caspase-8- and JNK-dependent AP-1 activation is required for Fas ligand-induced IL-8 production.
    Matsumoto N, Imamura R, Suda T.
    FEBS J; 2007 May 15; 274(9):2376-84. PubMed ID: 17403042
    [Abstract] [Full Text] [Related]

  • 17. Induction of apoptosis by pectenotoxin-2 is mediated with the induction of DR4/DR5, Egr-1 and NAG-1, activation of caspases and modulation of the Bcl-2 family in p53-deficient Hep3B hepatocellular carcinoma cells.
    Shin DY, Kim GY, Kim ND, Jung JH, Kim SK, Kang HS, Choi YH.
    Oncol Rep; 2008 Feb 15; 19(2):517-26. PubMed ID: 18202802
    [Abstract] [Full Text] [Related]

  • 18. Imatinib enhances human melanoma cell susceptibility to TRAIL-induced cell death: Relationship to Bcl-2 family and caspase activation.
    Hamaï A, Richon C, Meslin F, Faure F, Kauffmann A, Lecluse Y, Jalil A, Larue L, Avril MF, Chouaib S, Mehrpour M.
    Oncogene; 2006 Dec 07; 25(58):7618-34. PubMed ID: 16983347
    [Abstract] [Full Text] [Related]

  • 19. Bortezomib induces caspase-dependent apoptosis in Hodgkin lymphoma cell lines and is associated with reduced c-FLIP expression: a gene expression profiling study with implications for potential combination therapies.
    Zhao X, Qiu W, Kung J, Zhao X, Peng X, Yegappan M, Yen-Lieberman B, Hsi ED.
    Leuk Res; 2008 Feb 07; 32(2):275-85. PubMed ID: 17659339
    [Abstract] [Full Text] [Related]

  • 20. PACAP and C2-ceramide generate different AP-1 complexes through a MAP-kinase-dependent pathway: involvement of c-Fos in PACAP-induced Bcl-2 expression.
    Aubert N, Falluel-Morel A, Vaudry D, Xifro X, Rodriguez-Alvarez J, Fisch C, de Jouffrey S, Lebigot JF, Fournier A, Vaudry H, Gonzalez BJ.
    J Neurochem; 2006 Nov 07; 99(4):1237-50. PubMed ID: 17026529
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 37.